Seeking Expanded Genomic App List, 23andMe Releases Third-Party Developer API | GenomeWeb

Seeking to expand the range of applications available to research scientists and customers using its data, 23andMe this week released an application programming interface that will allow authorized third-party developers to build a broad range of apps for the web and mobile devices.

Mike Polcari, director of engineering at 23andMe, told BioInform that the Personal Genome API allows the company to benefit from the expertise of the broader developer community and could also lead to increased demand for its personal genome service.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.